Title: Iron Studies of HIV-Infected Subjects in Calabar- A Nigerian Perspective

Authors: Euphoria C. Akwiwu, Josephine O. Akpotuzor, Josephine E. Okon, Osagie Egharevba

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i3.195

Abstract

Investigating anaemia through screening tests could be insufficient in managing chronic infections. This study investigated the involvement of iron in the anaemia of human immunodeficiency virus infection. Participants were aged 19 to 50 years, comprising 76 infected subjects and 53 controls. The CD4+ count and haemoglobin concentration were determined by automation. Serum iron and total iron binding capacity were determined colorimetrically, while serum ferritin and interleukin-6 were analyzed by enzyme linked immunosorbent assay. Percentage of treatment- naïve subjects (61%) exceeded that of subjects on treatment (39%). Generally, 12%, 16% and 8% of the infected subjects had lower serum iron, total iron binding capacity and ferritin values respectively while 50%, 51% and 35% had values higher than the reference values respectively. However 38%, 33% and 57% of the infected subjects had their values within the reference limits. Approximately 45% of infected subjects had lower haemoglobin concentration, while 55% had values within range. The iron parameters of treatment naïve infected subjects did not significantly (P> 0.05) change when compared with those on treatment but significantly changed (P < 0.5) when compared with the control group. Degree of immunosuppression adjudged by the CD4+count was 31.5% for severe 48.7% advanced, 14.5% mild and only 5.3% normal. There are greater percentages of treatment naive subjects as well as severe immunosuppression in this locality. Approximately 45% anaemia prevalence was recorded in the studied infected population but the anaemia may not be a reflection of iron deficiency.

Keywords: Anaemia, Iron Studies, Human Immunodeficiency Virus.

References

1.      Bangsberg, DR, Perry S, Charlebois E D, Clark, R A, Roberston, M, Zolopa, A R, Moss, A    (2001) Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS Research Letters   15 (9) 1181-1183

2.      Panel on Antiretroviral Guidelines for Adults and Adolescents (2016). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.

3.      Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011;52:793-800.

4.      Friel, J. T. and  Scadden, T. D. (2011) Haematological manifestations of HIV Infection.  http://www.uptodate.com/ contents/hematologic_manifestation_of_hiv-infection-aknaemia

5.      Ogbe, P.J., Idoko O.A., Ezimah A.C., Digban K.A. and Oguntayo B.O. (2012). Evaluation of iron status in anaemia of chronic disease among patients with HIV infection. Clinical laboratory science 25(1):7-12.

6.      Sullivan PS, Hanson DL, Chu SY, Jones JL and Ward JW. (1998). Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood.;91(1):301-8.

7.      van Hensbroek  M. B., Jonker F.  and Bates I. (2011). Severe acquired anaemia in Africa: new concepts. British Journal of Haematology, 154: 690–695.

8.      Dieffenbach CW, Fauci AS. Thirty years of HIV and AIDS: future challenges and opportunities. Ann Intern Med 2011;154: 766-771.

9.      Lundgren JD and Mocroft A (2003).  Anemia and survival in human immunodeficiency virus. Clin Infect Dis 2003;37(suppl 4):S297303.

10.  O'Brien ME, Kupka R, Msamanga GI, Saathoff  E, Hunter DJ and Fawzi WW (2005) . Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania.  J Acquir Immune Defic Syndr;40:21925

11.  Obirikorang C., Issahaku R.G., Osakunor D.N.M and Osei-Yeboah J. (2016). Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana. AIDS Research and Treatment Article ID 1623094, 8 pages http://dx.doi.org/10.1155/2016/1623094

12.  McDermid J.M., Schim van der Loeff M.F., Jaye A., Hennig B.J., Bates C. Todd J., Sirugo G. Hill A.V., Whittle H.C. and  Prentice A.M. (2009) Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. The American Journal of Clinical Nutrition

13.  Hamlyn E, Fidler S, Stöhr W, Cooper DA, Tambussi G, Schechter M, Miro JM, Mcclure M, Weber J, Babiker A, Porter K; SPARTAC Trial Investigators. (2014). Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression. AIDS;28(6):869-74.

14.  World Health Organization (2013) Consolidated ARV guidelines of 2013. When to start ART in adults and adolescents: Rationale and supporting evidence. World Health Organization

15.  Althoff KN, Gange SJ, Klein MB, et al. (2010) Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis.;50(11):1512-1520. 

Corresponding Author

Euphoria C. Akwiwu

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.